A note from Jeff Pinto · healthcare-AI procurement · for IQVIA Canada (Healthcare Advisory)

Your clients are buying clinical AI on a demo and a handshake. Here's a scorecard your team could hand them.

I'd love to start with a short call to hear what your advisory engagements actually need. You're probably swamped, so I did some homework first.

So I built a small worked example, on a representative, public-archetype vendor field, of an evaluation method I've built before: a weighted scorecard and four structural questions that land a procurement verdict on one screen. It's a rough sketch on synthetic numbers, not your data and not a finished product, just a faster way to show what working together could look like than a blank-page call.

6 criteria
The weighted scorecard: Functionality 25, Cost 20, Ops 20, Experience 15, Architecture 10, Integration 10
4 questions
The structural gate: data control, whose outcome, how it fails safely, who owns the audit
$0 data
Client data the method touches: it runs on a representative field, behind your client's walls

What your clients are wrestling with

Your advisory team sells market access, health economics, and real world evidence to payors, manufacturers, hospitals, and provincial bodies. More of those engagements now hinge on a clinical-AI or data-vendor selection, and the procurement underneath it is thin: a demo, a slide about hallucinations, an unnameable reference customer, and a price line that isn't a bid, it's a conversation. The buyer signs anyway; 18 months later nobody owns whether the tool still does its job. Your clients carry that gap, and your consultants can't always staff a specialized evaluation against it on demand.

What the homework sketches

  • Four structural questions, run as a gate before any vendor is scored: data control, whose outcome the system optimises, how it fails safely, who owns the audit.
  • A weighted vendor scorecard, re-balanced per client, so the best demo doesn't win by default and an unscoreable bid gets flagged, not averaged in.
  • A model-monitoring ownership map: who re-runs the checks, who's accountable on drift, who answers the regulator. The month-18 question, named before signing.

Worked example, live: iqvia-scorecard.pages.dev (representative field, no client data).

Why me, not your own team

Your consultants could build a scorecard; a sophisticated team has the pieces. What an internal team can't easily hand a client is an outside examiner's objectivity on the vendor choice, the speed of a method already authored, and a track record the client can cite. The value is independence and a name on the method, not raw capability. I'd rather say that than oversell a slider.

The hunches behind the sketch (each falsifiable in your engagement)

1. Scored against four structural questions and a weighted scorecard, a procurement ranks differently, and more defensibly, than the demo-and-handshake most 2026 RFPs run.
Check it: score a client's real (anonymised) field both ways; see if the order moves.
2. A "usage-based, we'll work with you on price" cost line gets silently averaged in by a thin RFP, when it should be flagged unscoreable. A vendor you can't price you can't compare.
Check it: pull a recent shortlist's cost lines; count bids versus conversations.
3. The two strongest-demo vendors are often exactly the two with no named owner for "is this still doing its job in 18 months."
Check it: run the audit-ownership map on a signed contract; count duties with a name.
4. A foundation-model posture (buy, fine-tune, host-locally, abstain) belongs upstream of vendor selection; setting it first changes the eligible set before anyone is scored.
Check it: set the posture on a live engagement; watch which vendors drop out.

If it's a fit · a 4 to 6 week diagnostic

WK 1-2Build the four-question gate and the weighted scorecard with your consultants, tuned to the engagements you run most
WK 2-4Worked example on the client's own (anonymised) vendor field; the best demo ranks third, the unscoreable bid gets flagged
WK 4-6Model-monitoring ownership overlay and a one-page playbook your consultants perform with a client; the IP transfers to you

Pricing

Diagnostic: 4 to 6 weeks, method + worked example + playbook, IP transfers$55 to 75K
Year-one ceiling: diagnostic + governance overlay + one supervised live deployment, capped~$150K
Optional retainer: re-balancing as PHIPA and AI rules move; cancellable, queue-justified$8 to 12K / mo

Fixed-scope. Priced to fit inside an advisory engagement you've already sold; commercials in a one-page SOW after a call. The retainer is offered only if the method proves recurring reuse, never the default, not a platform fee.

The ask

One 30 to 45 minute call with the advisory lead. Bring one recent engagement where a clinical-AI or data vendor had to be chosen. I'll run that field through the four questions and the scorecard live, show where the demo-weighted and the defensible answers diverge, and hand you the one-page version your consultant performs tomorrow. If your team already scores this rigorously, I'll say so.

Book it: jeffpinto.com/engage · Method: the OMA procurement-scorecard note

Who's behind this

Jeff Pinto runs a small, independent data and AI advisory practice (jeffpinto.com). Thirty years across AI data and privacy, health tech, marketing analytics, renewables, logistics, and broadcasting; the last seven in ML and AI. Hands-on at Meta, Uber, and IBM, plus six startups (one turnaround, three acquisitions). Two MScs: computer science (Toronto) and engineering (Loughborough). Engagements are fixed-scope, four to twelve weeks, no platform and no subscription; whatever gets built, the IP transfers to you.

The edge for this one: the scorecard and the four questions aren't theory. I authored them in 2013 scoping the Ontario Medical Association's Big Data initiative against a roughly $263M four-year provincial eHealth budget, and I've evaluated healthcare-AI vendors across three decades since, including ML pipelines for psychiatric records at CAMH. The method has a paper trail; this is a re-application, not a cold pitch.

Sources: IQVIA FY2024 results (revenue $15.4B, ~88,000 employees in over 100 countries; company IR release) · IQVIA Canada Real World Solutions (advisory pillars: market access, HEOR, RWE) · the scorecard and four questions trace to Jeff's 2013 Ontario Medical Association Big Data engagement, scoped against a roughly $263M four-year provincial eHealth budget · regulatory frame: PHIPA. Vendor figures in the worked example are representative, not real vendor scores. Full workup in workbook.md.

Built by Jeff Pinto: Meta / Uber / IBM + 6 startups · two MScs · clinical-NLP and healthcare procurement (OMA, CAMH). jeffpinto.com

DRAFT · Updated 2026-06-19 · v0.2